REQUEST A DEMO
Total
USD $0.00
Search more companies

Industria Farmaceutica Indufar C Ltda (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Industria Farmaceutica Indufar C Ltda Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Industria Farmaceutica Indufar C Ltda is based in Ecuador, with the head office in Quito. It operates in the Pharmaceutical and Medicine Manufacturing industry. The enterprise was incorporated on September 01, 1982. There are currently 17 (2023) people employed by Industria Farmaceutica Indufar C Ltda. There was a net sales revenue drop of 1.62% reported in Industria Farmaceutica Indufar C Ltda’s latest financial highlights for 2023. Over the same period, its total assets grew by 14.41%.

Headquarters
Jaime Roldos Aguilera N14-122, Casa Bldg.
Quito; Pichincha;

Contact Details: Purchase the Industria Farmaceutica Indufar C Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Industria Farmaceutica Indufar C Ltda report to view the information.
Outstanding Shares:
Purchase the Industria Farmaceutica Indufar C Ltda report to view the information.
Registered Capital:
Purchase the Industria Farmaceutica Indufar C Ltda report to view the information.
Incorporation Date:
September 01, 1982
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
34%
Purchase this report to view the information.
34%
Purchase this report to view the information.
32%
Subsidiaries
Laboratorios Industriales Tecnologicos Ecuatorianos Labitech CIA Ltda
34.67%
Company Performance
Financial values in the chart are available after Industria Farmaceutica Indufar C Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-1.62%
Total operating revenue
-1.79%
Operating profit (EBIT)
N/A
EBITDA
224.26%
Net Profit (Loss) for the Period
N/A
Total assets
14.41%
Total equity
2.13%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-0.03%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?